Levels of IGF-1 and their relationship with bone mineral density in the premenopausal women with Fibromyalgia syndrome

Romatizma

Volumn 23, Issue 4, 2008, Pages 118-123

  Armaǧan, Onur ^a   Sirmagül, Esra ^a   Ekim, Ayşe ^a   Sirmagül, Başar ^a   Taşçioǧlu, Funda ^a   Öner, Cengiz ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Fibromyalgia; IGF 1; Osteoporosis

Indexed keywords

OSTEOCALCIN; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; BONE DENSITY; BONE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FIBROMYALGIA; HUMAN; LUMBAR VERTEBRA; OSTEOPOROSIS; PREMENOPAUSE;

EID: 69749087378     PISSN: 13005286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Wolfe F, Ross K, Anderson, Russel IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19-28.
2. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bomberdic C, Goldenberg DL, et al. The American College of Rheumatology 1990: criteria for the classification of fibromyalgia: Report of the Multi-Center Criteria Committee. Arthritis Rheum 1990; 33: 160-72.
3. Lawrence RC, Helmick CG, Arnett FC, Deyo Ra, Felson DT, Giannini EH, et al. Estimate of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41: 778-99.
4. Leal-Cerro A, Povedan J. Astorga OR, Gonzalez M, Silva H, and Garcia-Pesquera F. The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome, J Clin Endocrinol Metab 1999; 84: 3378-81.
5. Landis CA, Lentz MJ, Rothermel J, Riffle SC, Chapman D, and Buchwald D, et al., Decreased nocturnal levels of prolactin and growth hormone in women with fibromyalgia, J. Clin. Endocrinol. Metab 2001; 86: 1672-8.
6. Clauw DJ. The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia, Med. Hypotheses 1995; 44: 369-78.
7. Crofford LJ. Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, et al., Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia, Arthritis Rheum 1994; 37: 1583-92.
8. Crofford, LJ. Neuroendocrine abnormalities in fibromyalgia and related disorders, Am. J. Med. Sci 1998; 315: 359-66.
9. Bennett RM. Disordered growth hormone secretion in fibromyalgia: a review of recent findings and a hypothesized etiology, Z. Rheumatol 1998; 57 (Suppl. 2): 72-6.
10. Blum WF, Albertsson-Wikland K, Rosberg S, Ranker MB. Serum levels of insulin growth factor 1 (IGF 1) and IGF-1 binding protein 3 reflect spontaneous growth hormone secretion. Acta Endocrinol Metab 1993; 76: 1610-6.
11. Bennett RM. Adult growth hormone in patients fibromyalgia. Curr Rheumatol Rep 2002; 306-12.
12. Bonjour JP, Schurch MA, Chevalley T, Ammann P, Rizolli R. Protein intake. IGF-1 and osteoporosis. Osteoporosis Int 1997; 7: 36-42.
13. Bagge E, Bengtsson BA, Carlsson L, and Carlsson J. Low growth hormone secretion in patients with fibromyalgia-a preliminary report on 10 patients and 10 controls, J. Rheumatol 1998; 25: 145-8.
14. Bennett RM. Adult growth hormone deficiency in patients with fibromyalgia, Curr Rheumatol Rep 2002; 4: 306-12.
15. Moldofsky H, Scarisbick P, England R. et al. Musculoskeletal symptoms and non-REM sleep disturbance in patients with fibromyalgia syndrome and healthy subjects. Psyhosom Med 1975; 37: 341-51.
16. Bennett RM. Beyond fibromyalgia: Ideas on etiology and treatment. J Rheumatol Suppl. 1989; 19: 185-91.
17. Holl RW, Hartman ML, Veldhuis JD, Taylor WM, Thorner MO. Thirty-second sampling of plasma growth hormone in man: Correlation with sleep stages. J Clin Endocrinol Metab 1991: 72: 854-61.
18. Cuneo RC, Salomon F, McGauley GA, Sonksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol 1992; 37: 387-97.
19. Rosen T, Johansson G, Johansson JO, Bengtsson BA. Consequence of growth hormone deficiency in adults and the benefits and risk of recombinant human growth hormone treatment. A review paper. Horm Res 1995; 43: 93-9.
20. Jorgensen JOL, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hensen J, Skakkebaek NE. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989; 1: 1221-5.
21. Collins. D, Woods A, Herd R, Blake G, Fogelman I, Wheeter M. Insuline-like growth factor-1 and bone mineral density. Bone 23 1998; 23: 13-6.
22. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 1992; 74: 118-23.
23. Seck T, Scheppach B, Scharla S, Diel I, Blum WF, Bismer H. Concentration of insuline-like growth factor (IGF-1) and II in iliac crest bone matrix from pre-and postmenopausal women: Relationships to age, menopause, bone turnover, bone volume, and circulating IGF. J Clin Endocrinol Metab 1998; 83: 2331-1998.
24. Lindsay R. Consensus development statement. Who are the candidates for prevention and treatment of osteoporosis? Osteoporosis Int 1997; 7: 1-6.
25. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): conceptual and framework and item selection. Med Care 1992; 30:, 473-83.
26. Neumann L, Berzak A, Buskila D. Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36-item health survey (SF-36). Semin Arthritis Rheum 2000; 29: 400-8.
27. B Zerahn, H Bliddal, P Moller, et al. Bone mass in the calcaneus in patients with fibromyalgia. J Musculoskeletal Pain 2001; 9: 17-23.
28. Swezy RL, Adams J. Fibromyalgia: a risk factor for osteoporosis. J Rheumatol 1999; 26: 2642-4.
29. Burchardt CS, Mannerkorpi K, Hedenberg L Bjelle A. A randomized, controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 1994; 21: 714-20.
30. van Santen M Bolwijn P, Verstappen F, Bakker C, Hidding A, Houbent H, et al. A randomized clinical trial comparing fitness and biofeedback training versus basic treatment in patients with fibromyalgia. J Rheumatol 2002; 29: 575-81.
31. Swezey RL. Exercise for osteoporosis is walking enough? The case rol site specificity and resistive exercise. Spine 1996; 21: 2809-13.
32. Okumuş M, Gokoglu F, Kocaoglu S, Ceceli E, Yorgancioglu ZR. Muscle performance in patients with fibromyalgia. Singapore MED j 2006; 47: 752-65.
33. Valim V, Feldman D, Olivera L, et el. Low aerobic threshold and maximum oxygen uptake in fibromyalgia. Arthritis Rheum 1999; 42(suppl 19): 150.
34. Jensen B, Wittrup IH, Bliddal H, Danneskiold-Samsoer B, Faber J. Bone-mineral density in fibromyalgia patients-correlation to disease activity. Scand J Rheumatol 2003; 32:, 146-50.
35. McCall-Hosenfeld JS, Goldengerg DL, Hurtwitz, S, Adler GK. Growth hormone and Insulin-like growth factor-1 concentrations in women with fibromyalgia. J Rheumatol 2003; 30: 809-14.
36. Ferrociolli G, Guerra P, Rizzi V, Baraldo M, Salaffi F, Furlanut M. Somatomedine C (insuline-like growth factor 1) levels decrease during acute changes of stress related hormones. Relevance for fibromyalgia. J Rheumatol 1994; 21: 1332-4.
37. Bennett RM, Clark SR, Campell SM, Burckhardt CS. Low levels of somatomedine C in patients with fibromyalgia syndrome. Arthritis Rheum 1992; 35:1113-6.
38. RM Bennett, DM Cook, SR Clark, Burckhardt CS, Campell SM. Hypothalamic-pituitary-insuline-like growth factor-1 axis dysfunction in patients with fibromyalgia. J Rheumatol 1997; 24:1384-9.
39. Canalis E. Insulin-like growth factors and osteoporosis. Bone 1997; 21: 215-6.
40. Langlois JA, Rosen CJ, Visser M, et al. Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham heart study. J Clin Endocrinol Metab 1998; 83:4257-62.
41. Martini G, Valenti R, Giovani S, et al. Influence of insulin-like growth factor-I and leptin on bone mass in healthy post-menopausal women. Bone 2001; 28: 113-7.
42. Seck T, Bretz A, Krempien R, et al. Age-related changes in insulin-like growth factor I and II in human femoral cortical bone: lack of correlation with bone mass. Bone 1999: 87-393.
43. Poehlman ET, Toth MJ, Ades PA, et al. Menopause-associated changes in plasma lipids, insulin-like growth factor-I, and blood pressure: a longitudinal study. Eur J Clin Invest 1999; 27: 322-6.
44. Romagnoli E, Minisola S, Carnevale V, et al. Effect of estrogen deficiency on IGF-I plasma levels: relationship with bone mineral density in perimenopausal women. Calcif Tissue Int 1993; 53: 1-6